CEACAM1 and cancer: Cancer cells investigated in our study—GBM43 and U87MG—express TIM-3 ligands, including galectin-9 and CEACAM-1, with both dominating in percentage on GBM43 cells and in MFI on U87MG cells (Figure S14).